MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
202
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Percutaneous coronary intervention
Sponsor
Biotronik AG